Published on
May 4, 2021
- 12:00 GMT
Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Boosting Regimen Study
Study will evaluate safety and immunogenicity of multiple distinct dosing regimens of norovirus oral vaccine candidate Norovirus infects 15% of U.S. children under age five every year Study results may inform the COVID-19 oral vaccine program SOUTH SAN …
Distribution channels:
Media, Advertising & PR, Technology
...
